Opioid Abuse Treatment in Pregnancy

Similar documents
Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Non-Pharmacologic Treatment for Infants with Neonatal Abstinence Syndrome (NAS)

Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont

Addiction Recovery Support: Connecting Primary Care Providers and Community Resources

Maternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians

MOMS Project Panel Overview

Promoting Awareness of the Opioid Epidemic in Rural Vermont

Maine s Response to the Opiate Crisis. Christopher Pezzullo, DO State Health Officer Maine DHHS Maine CDC November 12, 2016

The Opioid-Exposed Woman

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome

Opioid Use Disorders and Pregnancy. Marcela Smid, MD Maternal-Fetal Medicine

Mental and Behavioral Health

Beyond Birth: A Comprehensive Recovery Center serving parenting women

KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH

Science = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse

Prenatal Substance Abuse: Improving Outcomes

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report

Opioid use in pregnancy and Neonatal Abstinence Syndrome

Medication-Assisted Treatment & Pregnancy. Dave Kneessy, MS, MAC, CAP, LMHC Regional Director Central Florida Treatment Centers

SUBSTANCE EXPOSED NEWBORNS

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015

Neonatal Abstinence Syndrome (NAS)

2/28/2017. Substance Use Disorders + Pregnancy. Substance Use Disorders + Pregnancy. + Prevalence of the Problem

Barriers to recovery for Buprenorphine Patients in Bangor, Maine

Substance-Exposed Newborns

Disclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond

Substance-Exposed Newborns

... Health. Department of. Prenatal Drug Exposure and Neonatal Abstinence Syndrome in Northeast TN. Overview and Regional Snapshot

Why NAS? Proposed Program

Effects of Prenatal Illicit Drug. Use on Infant and Child

Child Welfare and MOMS: Building Partnerships to Improve Care

The Impact of Addiction on Infant Mortality

Emerging Populations: Challenges for the Early Childhood System. Presented by Maureen Greer

Outcomes of Infants with Neonatal Abstinence Syndrome

Brief History of Methadone Maintenance Treatment

2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society

Pregnancy and Opioid Use

Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC.

Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016

Learning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons

REDUCING THE STIGMA OF OPIOID ADDICTION AMONG PERINATAL WOMEN. Lyn Raible, M.D., Ph.D. CMO, Aegis

Smoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018

Medication for the Treatment of Addiction (MAT)

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome

Opiate Use in Reproductive Age Females

An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women

INTRODUCTION. Baltimore, Maryland 6 School of Medicine West Virginia University, Morgantown, West Virginia

Vermont Guidelines for Obstetric Providers

Managing drug misuse in pregnancy and beyond

NEONATAL ABSTINENCE SYNDROME. NAS Kickoff 11/8/18

Prescription Opioids

Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Perinatal Opioid Use: Understanding and Aligning Response between Systems

Pregnancy, Opioid Addiction, and Care Issues in Virginia

8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY

Methadone and Pregnancy

Phil Breitenbucher, MSW, Children and Family Futures. Texas Behavioral Health Institute August 10-14, 2015

Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health

Consequences and Treatment of Opioid Abuse During Pregnancy. Katie Ellis, PharmD March 12, 2018

Continuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment

Test Your Knowledge: STI Questionnaire and Education

NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE

The Opioid Crisis among the Privately Insured

CDC s Efforts to End the Opioid Epidemic

HELPING OUR MOST VULNERABLE POPULATIONS IMPACTED BY THE OPIOID CRISIS: PREGNANT WOMEN, THEIR INFANTS, AND THOSE RECEIVING CHILD WELFARE SERVICES

Medication Assisted Treatment of Substance Use Disorders

Opioids in Pregnancy. Beyond to Baby GENERAL INFO

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works

Centering Healthcare is an outcome-driven, cost-effective, patient-centered model of care that

Behavioral Health Barometer. North Dakota, 2013

Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome

Case Management Policy and Procedures

2/24/2014. Bridging the Gap Between Behavioral Health and Pregnancy. My Background and Interest in the Topic... Plan for Today

EAT, SLEEP, CONSOLE The Yale Method of assessment and treatment of neonates during withdrawal from opiates

EI Leadership April 24, 2018

Improving Patient Education and Access to Anxiety Treatment

Prostate Cancer Screening Guidelines: Providing Patient Education

Ohio Perinatal Quality Collaborative

Care of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome?

Identification of Barriers to Organ Donation: A Primary Care Interventional Approach

Promoting Public Water Fluoridation in Bennington VT

PERINATAL TOBACCO USE

Use of Opioids for Pain Management: Educating Patients and Providers on Upcoming Changes to Vermont State Law

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

Abigail Plawman, MD. Addiction Medicine Fellowship Director MultiCare East Pierce Family Medicine.

Barriers To Recovery For Bangor's Buprenorphine Patients

Patient Education: Assessing the Barriers to Utilize & Create Effective Educational Resources for Type 2 Diabetes Mellitus (T2DM)

Status of Opioid Treatment Efforts

Anesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a

Assessing Access to Smoking Cessation Resources in Rural Populations

Vermont Food Insecurity: Implementing screening tools and interventional assistance at Thomas Chittenden Health Center

THE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA

NCACH RAPID CYCLE APPLICATION: OPIOID PROJECT North Central Accountable Community of Health - Medicaid Transformation Project

Substance-Exposed Newborn

The Impact of Neonatal Abstinence Syndrome: The View from a Rural Kentucky Hospital

Community Perception of Electronic Cigarettes and Their Role as Smoking Cessation Aids

Transcription:

University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2015 Opioid Abuse Treatment in Pregnancy Catherine A. Suppan Follow this and additional works at: https://scholarworks.uvm.edu/fmclerk Part of the Medical Education Commons, and the Primary Care Commons Recommended Citation Suppan, Catherine A., "Opioid Abuse Treatment in Pregnancy" (2015). Family Medicine Block Clerkship, Student Projects. 99. https://scholarworks.uvm.edu/fmclerk/99 This Book is brought to you for free and open access by the College of Medicine at ScholarWorks @ UVM. It has been accepted for inclusion in Family Medicine Block Clerkship, Student Projects by an authorized administrator of ScholarWorks @ UVM. For more information, please contact donna.omalley@uvm.edu.

Opioid Abuse Treatment in Pregnancy: Babies and Mothers Beginning In-sync CATHERINE SUPPAN MS -III RUTLAND PRIMARY CARE, RUTLAND VT AUGUST 2015-OCTOBER 2015 MENTORS: RICHARD BAKER, MD; JILL MERRILL, BSN, RN; JEREMY ASHTON, MS, LADC

The Problem: Opioid Abuse Opioid abuse remains an enormous issue in the United States 80% of the global opioid supply is consumed in the US Heroin use has increased across all age groups across the US as of 2014 As of 2008, there were are nearly 2 deaths per hour attributable to opioid use and abuse And in Vermont Vermont ranks second in per capita admissions for opioid treatment Opioid treatment budget for Vermont almost tripled between 2014 and 2015 Heroin and prescription opioid related deaths has increased annually as of 2013 in Vermont

An Even Bigger Problem: Opioid Abuse among Pregnant Women And among pregnant women The rate of maternal opioid abuse is rising 5.4% of pregnant women aged 15-44 are current illicit drug users in the US Rutland comes in slightly higher at almost 6.5% as of 2013 The rate of infants born exposed to opioids is increasing in Vermont 12.75% of babies born at RRMC were exposed to opioids in utero 20% of those babies moms were not recieving any kind of drug abuse treatment during pregnancy 25% of opioid exposed babies need treatment upon birth for withdrawal

What are the Costs? 85% of pregnancies in women who use opioids or are on MAT are unintentional This leads to psychosocial costs for families, direst expenditures, unplanned loss in productivity Maternal opioid abuse is associated with an odds ratio of 4.6 for in-hospital death for mom compared to non-using mothers The average length of stay for an opioid exposed baby (NAS baby) was 5.7 days in 2013, while only 2.6 for a non-nas baby In 2013, the average charge per infant exposed to opioids in utero in VT was $11,129 while that for non-nas babies was $4,739 In 2009, while the charge of delivering a NAS baby in Vermont was $9,064, nationally, it was $53,000! Additionally, opioid use in mom increases many risks to baby in-utero (though no specific syndrome has yet been identified in children exposed to opioids and most data on direct outcomes is controversial and limited) Infection (hepatitis B, C, HIV), decreased fetal growth, placental abruption, preterm labor, meconium aspiration, fetal death, possible low birth weight, neonatal abstinence syndrome and early life stress

The Need 1. A program specifically designed to help and treat pregnant women with opioid dependence issues 2. Comprehensive, appropriate and pertinent educational programming for women who wish to treat their opioid dependence 3. Community knowledge of the program among providers and patients 4. Community support for the program 5. A way to reach and attract patients in the community who are eligible and would benefit from the program

A Solution? Babies and Mothers Beginning In-sync (BAMBI) is a Rutland regional program aimed at providing comprehensive drug abuse, medical, social and community support to women who are pregnant, currently using non-prescribed opioids, and have the desire to stop. The program is monetarily supported by grants and the Rutland Regional Medical Center. It has served almost 100 women since its beginning in October 2011. BAMBI provides patients with support from: Rutland Regional Medical Center including Rutland Women s Healthcare, inpatient units, emergency department and staff physicians West Ridge Center for Addiction, Evergreen Substance Abuse Programs and Mental Health Services Physicians from Community Health Centers of Rutland Region, CHCRR Pediatrics, Green Mountain Family Medicine and Rutland Area Visiting Nurse Association and Hospice Medicaid, WIC, Children s Integrated Services, Food Stamps Additionally, BAMBI has contacts within the Agency of Human Services, including The Vermont Departments of Health, Corrections, Health Access and Children and Families.

Perspective: Discussions with Community Support To better understand the BAMBI program and assess its needs, I: Met with Jeremy Ashton, MS, LADC, a lead coordinator and educator for the BAMBI program Discussed what BAMBI entailed and program logistics, who the program served, and the strengths and weaknesses of BAMBI to gain a better understanding of how I could be involved. From this meeting, it was clear BAMBI needed to a way disseminate information about the program to women who were pregnant or recent mothers and interested in addressing their opioid abuse Met with Jill Merrill, BSN, RN, the care coordinator for BAMBI at Rutland Women s Healthcare Discussed program educational content and the role medical providers played in BAMBI, and got additional contact information for people who could provide me with data on BAMBI. From this meeting, I was able to determine what information would be the most helpful to put into the community and how to get it distributed throughout the community. Observed a weekly BAMBI session with current members, providers and community support to further understand the program as well as discuss the potential of creating more awareness of the program. This included gaining member perspective on BAMBI, getting feedback on how to best create awareness, and what the best information to disseminate would be.

Intervention and Methods Based on the information gathered from meetings with BAMBI staff and patients, I: Realized awareness about the BAMBI program came mostly from word-of-mouth and direct contact with BAMBI personnel who then referred women to the program. Additionally, BAMBI had an outdated poster for advertising that was not currently in production or in the community. Determined that a brochure women could find at various locations around the community would be an ideal resource to more effectively spread the word about BAMBI. Coordinated with BAMBI leaders to determine brochure content. Worked with Rutland Regional Medical Center public relations to ensure content and format were within RRMC publication guidelines. Developed a brochure for BAMBI to be stocked at community locations, including doctors offices, Rutland Regional Medical Center, substance abuse treatment centers, and mental health centers to increase awareness about the program amongst both patients and providers. Gathered anonymous feedback from the BAMBI group on the brochure to ensure it would be an effective tool

Response and Results: Qualitative Response among BAMBI staff BAMBI staff members were happy to meet with me, and were aware they needed a better way to create awareness about the program in the community. The brochure was approved and well received by the BAMBI staff members. BAMBI staff is excited to have an effective tool to create awareness of the program. The brochure is currently waiting approval with the Rutland Regional Medical Center public relations department for printing and distribution. Response among BABMI patients BAMBI staff members reported that the group members were more interactive and attentive during my visit, and they were happy to share their stories and experiences with me. Group members gave me feedback on what should be included in the brochure, the language to use, and how to most effectively reach the women BAMBI aims to engage. BAMBI members gave positive feedback on the finished brochure (next slide).

Response and Results: Quantitative Feedback on BAMBI Brochure from Current and Past BAMBI Members Would you pick this brochure up if you saw it? Would you read this brochure if you picked it up? Would you call BAMBI after reading this brochure? Was this brochure helpful? Yes Maybe 0 2 4 6 8 10 Number of Responses

Effectiveness and Limitations Effectiveness It is estimated that the brochure will be placed in over 100 locations around Rutland County, including hospitals, outpatient offices, drug abuse treatment centers, community resource centers, nonprofits, state department offices and so many more! Feedback from BAMBI members and staff indicate that most women who see the brochure will read it and call BAMBI, or at the least, read it and learn about drug addiction, pregnancy, and delivering an opioid exposed baby. Limitations Not all pregnant women are ready to tackle their drug addiction. Many pregnant women remain in the community, not seeking treatment for opioid abuse. Opioids are not the only drug pregnant women use. BAMBI and my brochure are aimed at opioid specific addiction. Not all pregnant women ready to face their addiction receive care or receive care where they would learn about BAMBI. Opioid abuse is not an issue limited to the Rutland region. Women outside this region need a program and resources too, and BAMBI does not have the capacity to help everyone, even with adequate awareness of the program. Rutland Regional Medical Center Public Relations had to vet the brochure. Content and timeline of distribution is ultimately dependent upon them. Despite suggestions that women who read the brochure will call to learn more about BAMBI, we do not know if these women will actually join or if they will be successful in the program.

Recommendations for Future Work 1. Streamline program content and improve communication between similar groups in the state There are several programs around the state aimed at helping pregnant women who abuse opioids. There is room for improvement in standardizing programming and communication between these groups and for creating a framework to set up more programs like them. 2. Develop tracking methods and questionnaires for BAMBI Tabulating information about the program would help to better understand successes and weak points within the program. 3. Develop a provider specific informational packet about BAMBI Many providers in the Rutland region are unaware that BAMBI exists, what it aims to accomplish, and the extent of resources BAMBI as access to. 4. Develop specific content for group sessions While BAMBI has a multitude of resources and programming in place, there is always room for improvement. BAMBI members attend many sessions throughout their time as patients, and are eager to learn many life and coping skills in addition to specifics about their health and addiction.

References Behnke & Smith. Prenatal Substance Abuse: Short- and Long-term Effects on the Exposed Fetus. Pediatrics. 2013; 131(3): e1009-e1024. Available: http://pediatrics.aappublications.org/content/131/3/e1009.full.pdf Blandthorn et al. Neonatal and maternal outcomes following maternal use of buprenorphine or methadone during pregnancy: findings of a retrospective audit. Women and Birth. 2011; 24(1): 32-39. Center for Behavioral Health Statistics and Quality. (2015) Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. HHS Publication No. SMA 15-4927, NSDUH Series H-50. Available: http://www.samhsa.gov/data/ Heil et al. Unintended pregnancy in opioid abusing women. Journal of Substance Abuse Treatment. 2011; 40(2): 199-202. Manchikanti & Singh. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician. 2008; 11(2 Suppl): S63-88. Available: http://www.samhsa.gov/data/population-data-nsduh Neonates Exposed to Opioids in Vermont. Vermont Uniform Hospital Discharge Data Set. Vermont Department of Health. http://healthvermont.gov/research/documents/opioids_neonate_exposure.pdf Substance Abuse and Mental Health Services Administration. (2014). Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD. Vermont Child Health Improvement Program. (2014). Evaluation and Report of Perinatal Statistics for Vermont Community Hospitals. Vermont Department of Health, Challenge of opioid addiction. June 2014. http://healthvermont.gov/adap/treatment/opioids/ Wanderer, Bateman, & Rathmell. Opioid use is rising. Anesthesiology. 2014; 121(6): A23.